Physician profile
David Lichtenstein
NPI 1861479594
$191,803.43
in general payments reported to CMS, 2019-2025
14 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $13K · 2021: $27K · 2022: $40K · 2023: $9,629 · 2024: $29K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Education: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,125.80 |
| Education | $13,311.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Food and Beverage | $1,141.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $78,718.22 | 2019-2025 | Hanarostent Esophagus Tts(Ccc), Single Use Biliary Balloon Dilator, Visiglide |
| Boston Scientific Corporation | $65,750.90 | 2020-2025 | Clinical Trial Product, Exalt Model D, Wallflex Duodenal |
| Teleflex LLC | $10,562.50 | 2025 | Barrigel |
| Palette Life Sciences, INC. | $10,175.00 | 2021-2022 | |
| Gyrus Acmi, INC. | $7,336.07 | 2020-2023 | |
| Ambu A/S | $6,586.57 | 2022-2023 | |
| Olympus Corporation | $2,915.00 | 2019-2025 | Single Use Electrosurgical Snare Sd-400 |
| Augmenix, INC. | $2,800.00 | 2019 | |
| Olympus America INC. | $2,584.92 | 2022 | |
| Olympus Medical Systems Corporation | $1,565.00 | 2024 | |
| Conmed Corporation | $1,407.50 | 2021 | |
| Ambu INC. | $1,025.00 | 2021 | |
| Apollo Endosurgery US INC | $292.44 | 2022 | |
| Pentax of America, INC. | $84.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lichtenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.